Results of an early access treatment protocol of daratumumab in United States patients with relapsed or refractory multiple myeloma.Published in:2018By:Chari, Ajai;Lonial, Sagar;Mark, Tomer M.;Krishnan, Amrita Y.;Stockerl‐Goldstein, Keith E.;Usmani, Saad Z.;Londhe, Anil;Etheredge, Delores;Fleming, Sarah;Liu, Baolian;Ukropec, Jon;Lin, Thomas S.;Jagannath, Sundar;Nooka, Ajay K.;Stockerl-Goldstein, Keith EPublication type:journal article